MorphoNet 2.0: An innovative approach for qualitative assessment and segmentation curation of large-scale 3D time-lapse imaging datasets

  1. Laboratoire d’informatique, de robotique et de microélectronique de Montpellier, LIRMM, Université de Montpellier, CNRS, Montpellier, France
  2. Centre de Recherche de Biologie cellulaire de Montpellier, CRBM, Université de Montpellier, CNRS, Montpellier, France
  3. Montpellier Ressources Imagerie, Biocampus, Université de Montpellier, CNRS, INSERM, Montpellier, France

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a provisional response from the authors.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Martin Graña
    Institut Pasteur de Montevideo, Montevideo, Uruguay
  • Senior Editor
    Aleksandra Walczak
    CNRS, Paris, France

Reviewer #1 (Public review):

The authors present a substantial improvement to their existing tool, MorphoNet, intended to facilitate assessment of 3D+t cell segmentation and tracking results, and curation of high-quality analysis for scientific discovery and data sharing. These tools are provided through a user-friendly GUI, making them accessible to biologists who are not experienced coders. Further, the authors have re-developed this tool to be a locally installed piece of software instead of a web interface, making the analysis and rendering of large 3D+t datasets more computationally efficient. The authors evidence the value of this tool with a series of use cases, in which they apply different features of the software to existing datasets and show the improvement to the segmentation and tracking achieved.

While the computational tools packaged in this software are familiar to readers (e.g., cellpose), the novel contribution of this work is the focus on error correction. The MorphoNet 2.0 software helps users identify where their candidate segmentation and/or tracking may be incorrect. The authors then provide existing tools in a single user-friendly package, lowering the threshold of skill required for users to get maximal value from these existing tools. To help users apply these tools effectively, the authors introduce a number of unsupervised quality metrics that can be applied to a segmentation candidate to identify masks and regions where the segmentation results are noticeably different from the majority of the image.

This work is valuable to researchers who are working with cell microscopy data that requires high-quality segmentation and tracking, particularly if their data are 3D time-lapse and thus challenging to segment and assess. The MorphoNet 2.0 tool that the authors present is intended to make the iterative process of segmentation, quality assessment, and re-processing easier and more streamlined, combining commonly used tools into a single user interface.

One of the key contributions of the work is the unsupervised metrics that MorphoNet 2.0 offers for segmentation quality assessment. These metrics are used in the use cases to identify low-quality instances of segmentation in the provided datasets, so that they can be improved with plugins directly in MorphoNet 2.0. However, not enough consideration is given to demonstrating that optimizing these metrics leads to an improvement in segmentation quality. For example, in Use Case 1, the authors report their metrics of interest (Intensity offset, Intensity border variation, and Nuclei volume) for the uncurated silver truth, the partially curated and fully curated datasets, but this does not evidence an improvement in the results. Additional plotting of the distribution of these metrics on the Gold Truth data could help confirm that the distribution of these metrics now better matches the expected distribution.

Similarly, in Use Case 2, visual inspection leads us to believe that the segmentation generated by the Cellpose + Deli pipeline (shown in Figure 4d) is an improvement, but a direct comparison of agreement between segmented masks and masks in the published data (where the segmentations overlap) would further evidence this.

We would appreciate the authors addressing the risk of decreasing the quality of the segmentations by applying circular logic with their tool; MorphoNet 2.0 uses unsupervised metrics to identify masks that do not fit the typical distribution. A model such as StarDist can be trained on the "good" masks to generate more masks that match the most common type. This leads to a more homogeneous segmentation quality, without consideration for whether these metrics actually optimize the segmentation

In Use case 5, the authors include details that the errors were corrected by "264 MorphoNet plugin actions ... in 8 hours actions [sic]". The work would benefit from explaining whether this is 8 hours of human work, trying plugins and iteratively improving, or 8 hours of compute time to apply the selected plugins.

Reviewer #2 (Public review):

Summary:

This article presents Morphonet 2.0, a software designed to visualise and curate segmentations of 3D and 3D+t data. The authors demonstrate their capabilities on five published datasets, showcasing how even small segmentation errors can be automatically detected, easily assessed, and corrected by the user. This allows for more reliable ground truths, which will in turn be very much valuable for analysis and training deep learning models. Morphonet 2.0 offers intuitive 3D inspection and functionalities accessible to a non-coding audience, thereby broadening its impact.

Strengths:

The work proposed in this article is expected to be of great interest to the community by enabling easy visualisation and correction of complex 3D(+t) datasets. Moreover, the article is clear and well written, making MorphoNet more likely to be used. The goals are clearly defined, addressing an undeniable need in the bioimage analysis community. The authors use a diverse range of datasets, successfully demonstrating the versatility of the software.

We would also like to highlight the great effort that was made to clearly explain which type of computer configurations are necessary to run the different datasets and how to find the appropriate documentation according to your needs. The authors clearly carefully thought about these two important problems and came up with very satisfactory solutions.

Weaknesses:

There is still one concern: the quantification of the improvement of the segmentations in the use cases and, therefore, the quantification of the potential impact of the software. While it appears hard to quantify the quality of the correction, the proposed work would be significantly improved if such metrics could be provided.

The authors show some distributions of metrics before and after segmentations to highlight the changes. This is a great start, but there seem to be two shortcomings: first, the comparison and interpretation of the different distributions does not appear to be trivial. It is therefore difficult to judge the quality of the improvement from these. Maybe an explanation in the text of how to interpret the differences between the distributions could help. A second shortcoming is that the before/after metrics displayed are the metrics used to guide the correction, so, by design, the scores will improve, but does that accurately represent the improvement of the segmentation? It seems to be the case, but it would be nice to maybe have a better assessment of the improvement of the quality.

Reviewer #3 (Public review):

Summary:

A very thorough technical report of a new standalone, open-source software for microscopy image processing and analysis (MorphoNet 2.0), with a particular emphasis on automated segmentation and its curation to obtain accurate results even with very complex 3D stacks, including timelapse experiments.

Strengths:

The authors did a good job of explaining the advantages of MorphoNet 2.0, as compared to its previous web-based version and to other software with similar capabilities. What I particularly found more useful to actually envisage these claimed advantages is the five examples used to illustrate the power of the software (based on a combination of Python scripting and the 3D game engine Unity). These examples, from published research, are very varied in both types of information and image quality, and all have their complexities, making them inherently difficult to segment. I strongly recommend the readers to carefully watch the accompanying videos, which show (although not thoroughly) how the software is actually used in these examples.

Weaknesses:

Being a technical article, the only possible comments are on how methods are presented, which is generally adequate, as mentioned above. In this regard, and in spite of the presented examples (chosen by the authors, who clearly gave them a deep thought before showing them), the only way in which the presented software will prove valuable is through its use by as many researchers as possible. This is not a weakness per se, of course, but just what is usual in this sort of report. Hence, I encourage readers to download the software and give it time to test it on their own data (which I will also do myself).

In conclusion, I believe that this report is fundamental because it will be the major way of initially promoting the use of MorphoNet 2.0 by the objective public. The software itself holds the promise of being very impactful for the microscopists' community.

Author response:

eLife Assessment

This work presents an important technical advancement with the release of MorphoNet 2.0, a user-friendly, standalone platform for 3D+T segmentation and analysis in biological imaging. The authors provide convincing evidence of the tool's capabilities through illustrative use cases, though broader validation against current state-of-the-art tools would strengthen its position. The software's accessibility and versatility make it a resource that will be of value for the bioimaging community, particularly in specialized subfields.

We would like to thank the editors and reviewers for their careful and constructive evaluation of our manuscript “MorphoNet 2.0: An innovative approach for qualitative assessment and segmentation curation of large-scale 3D time-lapse imaging datasets”. We are grateful for the positive assessment of MorphoNet 2.0 as a valuable and accessible tool for the bioimaging community, and for the recognition of its technical advancements, particularly in the context of complex 3D+t segmentation tasks.

The reviewers have highlighted several important points that we will address in the revised manuscript. These include:

- The need for a clearer demonstration that improvements in unsupervised quality metrics correspond to actual improvements in segmentation quality. In response, we will provide comparisons with gold standard annotations where available and clarify how to interpret metric distributions.
- The potential risk of circular logic when using unsupervised metrics to guide model training. We now explicitly discuss this limitation and emphasize the importance of external validation and expert input.
- The value of comparing MorphoNet 2.0 to other tools such as FIJI and napari. We will include a comparative table to help readers understand MorphoNet’s positioning and complementarity.
- The importance of clearer documentation and terminology. We will overhaul the help pages, standardize plugin naming, and add a glossary-style table to the manuscript.
- Suggestions for future developments, such as mesh export and interoperability with napari, which we will explore for the revision.

We appreciate the detailed feedback on both scientific and editorial aspects, including corrections to figures and text, and we will integrate all suggested revisions to improve the manuscript’s clarity and impact. We are confident that these changes will strengthen the manuscript and enhance the utility of MorphoNet 2.0 for the community.

Public Reviews:

Reviewer #1 (Public review):

The authors present a substantial improvement to their existing tool, MorphoNet, intended to facilitate assessment of 3D+t cell segmentation and tracking results, and curation of high-quality analysis for scientific discovery and data sharing. These tools are provided through a user-friendly GUI, making them accessible to biologists who are not experienced coders. Further, the authors have re-developed this tool to be a locally installed piece of software instead of a web interface, making the analysis and rendering of large 3D+t datasets more computationally efficient. The authors evidence the value of this tool with a series of use cases, in which they apply different features of the software to existing datasets and show the improvement to the segmentation and tracking achieved.

While the computational tools packaged in this software are familiar to readers (e.g., cellpose), the novel contribution of this work is the focus on error correction. The MorphoNet 2.0 software helps users identify where their candidate segmentation and/or tracking may be incorrect. The authors then provide existing tools in a single user-friendly package, lowering the threshold of skill required for users to get maximal value from these existing tools. To help users apply these tools effectively, the authors introduce a number of unsupervised quality metrics that can be applied to a segmentation candidate to identify masks and regions where the segmentation results are noticeably different from the majority of the image.

This work is valuable to researchers who are working with cell microscopy data that requires high-quality segmentation and tracking, particularly if their data are 3D time-lapse and thus challenging to segment and assess. The MorphoNet 2.0 tool that the authors present is intended to make the iterative process of segmentation, quality assessment, and re-processing easier and more streamlined, combining commonly used tools into a single user interface.

We sincerely thank the reviewer for their thorough and encouraging evaluation of our work. We are grateful that they highlighted both the technical improvements of MorphoNet 2.0 and its potential impact for the broader community working with complex 3D+t microscopy datasets. We particularly appreciate the recognition of our efforts to make advanced segmentation and tracking tools accessible to non-expert users through a user-friendly and locally installable interface, and for pointing out the importance of error detection and correction in the iterative analysis workflow. The reviewer’s appreciation of the value of integrating unsupervised quality metrics to support this process is especially meaningful to us, as this was a central motivation behind the development of MorphoNet 2.0. We hope the tool will indeed facilitate more rigorous and reproducible analyses, and we are encouraged by the reviewer’s positive assessment of its utility for the community.

One of the key contributions of the work is the unsupervised metrics that MorphoNet 2.0 offers for segmentation quality assessment. These metrics are used in the use cases to identify low-quality instances of segmentation in the provided datasets, so that they can be improved with plugins directly in MorphoNet 2.0. However, not enough consideration is given to demonstrating that optimizing these metrics leads to an improvement in segmentation quality. For example, in Use Case 1, the authors report their metrics of interest (Intensity offset, Intensity border variation, and Nuclei volume) for the uncurated silver truth, the partially curated and fully curated datasets, but this does not evidence an improvement in the results. Additional plotting of the distribution of these metrics on the Gold Truth data could help confirm that the distribution of these metrics now better matches the expected distribution.

Similarly, in Use Case 2, visual inspection leads us to believe that the segmentation generated by the Cellpose + Deli pipeline (shown in Figure 4d) is an improvement, but a direct comparison of agreement between segmented masks and masks in the published data (where the segmentations overlap) would further evidence this.

We agree that demonstrating the correlation between metric optimization and real segmentation improvement is essential. We will add new analysis comparing the distributions of the unsupervised metrics with the gold truth data before and after curation. Additionally, we will provide overlap scores where ground truth annotations are available, confirming the improvement. We will also explicitly discuss the limitation of relying solely on unsupervised metrics without complementary validation.

We would appreciate the authors addressing the risk of decreasing the quality of the segmentations by applying circular logic with their tool; MorphoNet 2.0 uses unsupervised metrics to identify masks that do not fit the typical distribution. A model such as StarDist can be trained on the "good" masks to generate more masks that match the most common type. This leads to a more homogeneous segmentation quality, without consideration for whether these metrics actually optimize the segmentation

We thank the reviewer for this important and insightful comment. It raises a crucial point regarding the risk of circular logic in our segmentation pipeline. Indeed, relying on unsupervised metrics to select “good” masks and using them to train a model like StarDist could lead to reinforcing a particular distribution of shapes or sizes, potentially filtering out biologically relevant variability. This homogenization may improve consistency with the chosen metrics, but not necessarily with the true underlying structures.

We fully agree that this is a key limitation to be aware of. We will revise the manuscript to explicitly discuss this risk, emphasizing that while our approach may help improve segmentation quality according to specific criteria, it should be complemented with biological validation and, when possible, expert input to ensure that important but rare phenotypes are not excluded.

In Use case 5, the authors include details that the errors were corrected by "264 MorphoNet plugin actions ... in 8 hours actions [sic]". The work would benefit from explaining whether this is 8 hours of human work, trying plugins and iteratively improving, or 8 hours of compute time to apply the selected plugins.

We will clarify that the “8 hours” refer to human interaction time, including exploration, testing, and iterative correction using plugins.

Reviewer #2 (Public review):

Summary:

This article presents Morphonet 2.0, a software designed to visualise and curate segmentations of 3D and 3D+t data. The authors demonstrate their capabilities on five published datasets, showcasing how even small segmentation errors can be automatically detected, easily assessed, and corrected by the user. This allows for more reliable ground truths, which will in turn be very much valuable for analysis and training deep learning models. Morphonet 2.0 offers intuitive 3D inspection and functionalities accessible to a non-coding audience, thereby broadening its impact.

Strengths:

The work proposed in this article is expected to be of great interest to the community by enabling easy visualisation and correction of complex 3D(+t) datasets. Moreover, the article is clear and well written, making MorphoNet more likely to be used. The goals are clearly defined, addressing an undeniable need in the bioimage analysis community. The authors use a diverse range of datasets, successfully demonstrating the versatility of the software.

We would also like to highlight the great effort that was made to clearly explain which type of computer configurations are necessary to run the different datasets and how to find the appropriate documentation according to your needs. The authors clearly carefully thought about these two important problems and came up with very satisfactory solutions.

We would like to sincerely thank the reviewer for their positive and thoughtful feedback. We are especially grateful that they acknowledged the clarity of the manuscript and the potential value of MorphoNet 2.0 for the community, particularly in facilitating the visualization and correction of complex 3D(+t) datasets. We also appreciate the reviewer’s recognition of our efforts to provide detailed guidance on hardware requirements and access to documentation—two aspects we consider crucial to ensuring the tool is both usable and widely adopted. Their comments are very encouraging and reinforce our commitment to making MorphoNet 2.0 as accessible and practical as possible for a broad range of users in the bioimage analysis community.

Weaknesses:

There is still one concern: the quantification of the improvement of the segmentations in the use cases and, therefore, the quantification of the potential impact of the software. While it appears hard to quantify the quality of the correction, the proposed work would be significantly improved if such metrics could be provided.

The authors show some distributions of metrics before and after segmentations to highlight the changes. This is a great start, but there seem to be two shortcomings: first, the comparison and interpretation of the different distributions does not appear to be trivial. It is therefore difficult to judge the quality of the improvement from these. Maybe an explanation in the text of how to interpret the differences between the distributions could help. A second shortcoming is that the before/after metrics displayed are the metrics used to guide the correction, so, by design, the scores will improve, but does that accurately represent the improvement of the segmentation? It seems to be the case, but it would be nice to maybe have a better assessment of the improvement of the quality.

We thank the reviewer for this constructive and important comment. We fully agree that assessing the true quality improvement of segmentation after correction is a central and challenging issue. While we initially focused on changes in the unsupervised quality metrics to illustrate the effect of the correction, we acknowledge that interpreting these distributions may not be straightforward, and that relying solely on the metrics used to guide the correction introduces an inherent bias in the evaluation.

To address the first point, we will revise the manuscript to provide clearer guidance on how to interpret the changes in metric distributions before and after correction, with additional examples to make this interpretation more intuitive.

Regarding the second point, we agree that using independent, external validation is necessary to confirm that the segmentation has genuinely improved. To this end, we will include additional assessments using complementary evaluation strategies on selected datasets where ground truth is accessible, to compare pre- and post-correction segmentations with an independent reference. These results reinforce the idea that the corrections guided by unsupervised metrics generally lead to more accurate segmentations, but we also emphasize their limitations and the need for biological validation in real-world cases.

Reviewer #3 (Public review):

Summary:

A very thorough technical report of a new standalone, open-source software for microscopy image processing and analysis (MorphoNet 2.0), with a particular emphasis on automated segmentation and its curation to obtain accurate results even with very complex 3D stacks, including timelapse experiments.

Strengths:

The authors did a good job of explaining the advantages of MorphoNet 2.0, as compared to its previous web-based version and to other software with similar capabilities. What I particularly found more useful to actually envisage these claimed advantages is the five examples used to illustrate the power of the software (based on a combination of Python scripting and the 3D game engine Unity). These examples, from published research, are very varied in both types of information and image quality, and all have their complexities, making them inherently difficult to segment. I strongly recommend the readers to carefully watch the accompanying videos, which show (although not thoroughly) how the software is actually used in these examples.

We sincerely thank the reviewer for their thoughtful and encouraging feedback. We are particularly pleased that the reviewer appreciated the comparative analysis of MorphoNet 2.0 with both its earlier version and existing tools, as well as the relevance of the five diverse and complex use cases we selected. Demonstrating the software’s versatility and robustness across a variety of challenging datasets was a key goal of this work, and we are glad that this aspect came through clearly. We also appreciate the reviewer’s recommendation to watch the accompanying videos, which we designed to provide a practical sense of how the tool is used in real-world scenarios. Their positive assessment is highly motivating and reinforces the value of combining scripting flexibility with an interactive 3D interface.

Weaknesses:

Being a technical article, the only possible comments are on how methods are presented, which is generally adequate, as mentioned above. In this regard, and in spite of the presented examples (chosen by the authors, who clearly gave them a deep thought before showing them), the only way in which the presented software will prove valuable is through its use by as many researchers as possible. This is not a weakness per se, of course, but just what is usual in this sort of report. Hence, I encourage readers to download the software and give it time to test it on their own data (which I will also do myself).

We fully agree that the true value of MorphoNet 2.0 will be demonstrated through its practical use by a wide range of researchers working with complex 3D and 3D+t datasets. In this regard, we will improve the user documentation and provide a set of example datasets to help new users quickly familiarize themselves with the platform. We are also committed to maintaining and updating MorphoNet 2.0 based on user feedback to further support its usability and impact.

In conclusion, I believe that this report is fundamental because it will be the major way of initially promoting the use of MorphoNet 2.0 by the objective public. The software itself holds the promise of being very impactful for the microscopists' community.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation